272 related articles for article (PubMed ID: 25079037)
1. E-cadherin loss alters cytoskeletal organization and adhesion in non-malignant breast cells but is insufficient to induce an epithelial-mesenchymal transition.
Chen A; Beetham H; Black MA; Priya R; Telford BJ; Guest J; Wiggins GA; Godwin TD; Yap AS; Guilford PJ
BMC Cancer; 2014 Jul; 14():552. PubMed ID: 25079037
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratin 18 is necessary for initiation of TGF-β1-induced epithelial-mesenchymal transition in breast epithelial cells.
Jung H; Kim B; Moon BI; Oh ES
Mol Cell Biochem; 2016 Dec; 423(1-2):21-28. PubMed ID: 27734227
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function.
Godwin TD; Kelly ST; Brew TP; Bougen-Zhukov NM; Single AB; Chen A; Stylianou CE; Harris LD; Currie SK; Telford BJ; Beetham HG; Evans GB; Black MA; Guilford PJ
Gastric Cancer; 2019 Mar; 22(2):273-286. PubMed ID: 30066183
[TBL] [Abstract][Full Text] [Related]
4. Loss of E-cadherin expression is not a prerequisite for c-erbB2-induced epithelial-mesenchymal transition.
Nilsson GM; Akhtar N; Kannius-Janson M; Baeckström D
Int J Oncol; 2014 Jul; 45(1):82-94. PubMed ID: 24807161
[TBL] [Abstract][Full Text] [Related]
5. [Morphology, cell-cell interactions, and migratory activity of IAR-2 epithelial cells transformed with the RAS oncogene: contribution of cell adhesion protein E-cadherin].
Zhitniak IIu; Glushankova NA
Ontogenez; 2011; 42(6):453-64. PubMed ID: 22288108
[TBL] [Abstract][Full Text] [Related]
6. HOXA5 determines cell fate transition and impedes tumor initiation and progression in breast cancer through regulation of E-cadherin and CD24.
Teo WW; Merino VF; Cho S; Korangath P; Liang X; Wu RC; Neumann NM; Ewald AJ; Sukumar S
Oncogene; 2016 Oct; 35(42):5539-5551. PubMed ID: 27157614
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-mesenchymal transition in breast epithelial cells treated with cadmium and the role of Snail.
Wei Z; Shan Z; Shaikh ZA
Toxicol Appl Pharmacol; 2018 Apr; 344():46-55. PubMed ID: 29501589
[TBL] [Abstract][Full Text] [Related]
8. Chronic Leptin Treatment Induces Epithelial-Mesenchymal Transition in MCF10A Mammary Epithelial Cells.
Juárez-Cruz JC; Okoniewski M; Ramírez M; Ortuño-Pineda C; Navarro-Tito N; Castañeda-Saucedo E
J Mammary Gland Biol Neoplasia; 2022 Mar; 27(1):19-36. PubMed ID: 35195812
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic silencing of genes enhanced by collective role of reactive oxygen species and MAPK signaling downstream ERK/Snail axis: Ectopic application of hydrogen peroxide repress CDH1 gene by enhanced DNA methyltransferase activity in human breast cancer.
Pradhan N; Parbin S; Kar S; Das L; Kirtana R; Suma Seshadri G; Sengupta D; Deb M; Kausar C; Patra SK
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1651-1665. PubMed ID: 30954555
[TBL] [Abstract][Full Text] [Related]
10. Cofilin-1 signaling mediates epithelial-mesenchymal transition by promoting actin cytoskeleton reorganization and cell-cell adhesion regulation in colorectal cancer cells.
Sousa-Squiavinato ACM; Rocha MR; Barcellos-de-Souza P; de Souza WF; Morgado-Diaz JA
Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):418-429. PubMed ID: 30296500
[TBL] [Abstract][Full Text] [Related]
11. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
Hollestelle A; Peeters JK; Smid M; Timmermans M; Verhoog LC; Westenend PJ; Heine AA; Chan A; Sieuwerts AM; Wiemer EA; Klijn JG; van der Spek PJ; Foekens JA; Schutte M; den Bakker MA; Martens JW
Breast Cancer Res Treat; 2013 Feb; 138(1):47-57. PubMed ID: 23338761
[TBL] [Abstract][Full Text] [Related]
12. Actin cytoskeleton regulation of epithelial mesenchymal transition in metastatic cancer cells.
Shankar J; Nabi IR
PLoS One; 2015; 10(3):e0119954. PubMed ID: 25756282
[TBL] [Abstract][Full Text] [Related]
13. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis.
Shriver M; Stroka KM; Vitolo MI; Martin S; Huso DL; Konstantopoulos K; Kontrogianni-Konstantopoulos A
Oncogene; 2015 Aug; 34(32):4248-59. PubMed ID: 25381817
[TBL] [Abstract][Full Text] [Related]
14. Cadherin 6 promotes neural crest cell detachment via F-actin regulation and influences active Rho distribution during epithelial-to-mesenchymal transition.
Clay MR; Halloran MC
Development; 2014 Jun; 141(12):2506-15. PubMed ID: 24917505
[TBL] [Abstract][Full Text] [Related]
15. Native type IV collagen induces an epithelial to mesenchymal transition-like process in mammary epithelial cells MCF10A.
Espinosa Neira R; Salazar EP
Int J Biochem Cell Biol; 2012 Dec; 44(12):2194-203. PubMed ID: 22981734
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin-downregulation and RECK-upregulation are coupled in the non-malignant epithelial cell line MCF10A but not in multiple carcinoma-derived cell lines.
Yuki K; Yoshida Y; Inagaki R; Hiai H; Noda M
Sci Rep; 2014 Apr; 4():4568. PubMed ID: 24691523
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Rho GAP GRAF1 in maintenance of epithelial phenotype.
Regev M; Sabanay H; Kartvelishvily E; Kam Z; Bershadsky AD
Cell Adh Migr; 2017 Jul; 11(4):367-383. PubMed ID: 27588930
[TBL] [Abstract][Full Text] [Related]
18. RAC1B: A Guardian of the Epithelial Phenotype and Protector Against Epithelial-Mesenchymal Transition.
Zinn R; Otterbein H; Lehnert H; Ungefroren H
Cells; 2019 Dec; 8(12):. PubMed ID: 31817229
[TBL] [Abstract][Full Text] [Related]
19. Proteomics analysis of E-cadherin knockdown in epithelial breast cancer cells.
Vergara D; Simeone P; Latorre D; Cascione F; Leporatti S; Trerotola M; Giudetti AM; Capobianco L; Lunetti P; Rizzello A; Rinaldi R; Alberti S; Maffia M
J Biotechnol; 2015 May; 202():3-11. PubMed ID: 25449012
[TBL] [Abstract][Full Text] [Related]
20. Rb depletion results in deregulation of E-cadherin and induction of cellular phenotypic changes that are characteristic of the epithelial-to-mesenchymal transition.
Arima Y; Inoue Y; Shibata T; Hayashi H; Nagano O; Saya H; Taya Y
Cancer Res; 2008 Jul; 68(13):5104-12. PubMed ID: 18593909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
